Work

The Evolution of Fluorescence-Guided Surgery

Year: 2022

Type: review

Abstract: There has been continual development of fluorescent agents, imaging systems, and their applications over the past several decades. With the recent FDA approvals of 5-aminolevulinic acid, hexaminolevulinate, and pafolacianine, much of the potential that fluorescence offers for image-guided oncologic surgery is now being actualized. In this article, we review the evolution of fluorescence-guided surgery, highlight the milestones which have contributed to successful clinical translation, and examine the future of targeted fluorescence imaging.

Source: Molecular Imaging and Biology

DOI: 10.1007/s11307-022-01772-8

Authors: Stan Van Keulen, Marisa Hom, Haley White, Eben L. Rosenthal, Fred M Baik

Institutions: Amsterdam University Medical Centers, Vanderbilt University Medical Center, Stanford Medicine, Stanford University

Language: English

Topic: Photodynamic Therapy Research Studies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $3,860